Training in flexible intensive insulin therapy improves quality of life, decreases the risk of hypoglycaemia and ameliorates poor metabolic control in patients with type 1 diabetes

Diabetes Research and Clinical Practice

Volumn 83, Issue 3, 2009, Pages 327-333

  Bendik, C Falconnier ^a   Keller, U ^a   Moriconi, N ^a   Gessler, A ^a   Schindler, Ch ^b   Zulewski, H ^a   Ruiz, J ^c   Puder, J J ^c  

^a UNIVERSITY OF BASEL   (Switzerland)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Diabetes type 1; Insulin; Patient education; Quality of life

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADULT; AGED; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH EDUCATION; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLIC PARAMETERS; METABOLIC REGULATION; OUTCOME ASSESSMENT; QUALITY OF LIFE; RISK FACTOR; SELF CONTROL; SELF MONITORING;

DIABETES MELLITUS, TYPE 1; HEMOGLOBIN A, GLYCOSYLATED; HOSPITALS, UNIVERSITY; HUMANS; HYPOGLYCEMIA; INFORMED CONSENT; INSULIN; INTERNAL-EXTERNAL CONTROL; KNOWLEDGE; OUTPATIENTS; PATIENT EDUCATION AS TOPIC; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SELF CARE; SWITZERLAND;

EID: 59349120564     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.11.034     Document Type: Article

References (29)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
2. The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the diabetes control and complications trial. Diabetes 46 (1997) 271-286
3. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ 325 (2002) 746-752
4. Langewitz W., Wossmer B., Iseli J., and Berger W. Psychological and metabolic improvement after an outpatient teaching program for functional intensified insulin therapy (FIT). Diabetes Res Clin Pract 37 (1997) 157-164
5. Pieber T.R., Brunner G.A., Schnedl W.J., Schattenberg S., Kaufmann P., and Krejs G.J. Evaluation of a structured outpatient group education program for intensive insulin therapy. Diabetes Care 18 (1995) 625-630
6. Schiel R., Muller U.A., and Ulbrich S. Long-term efficacy of a 5-day structured teaching and treatment programme for intensified conventional insulin therapy and risk for severe hypoglycemia. Diabetes Res Clin Pract 35 (1997) 41-48
7. Bott S., Bott U., Berger M., and Muhlhauser I. Intensified insulin therapy and the risk of severe hypoglycaemia. Diabetologia 40 (1997) 926-932
8. Howorka K., Pumprla J., Wagner-Nosiska D., Grillmayr H., Schlusche C., and Schabmann A. Empowering diabetes out-patients with structured education: short-term and long-term effects of functional insulin treatment on perceived control over diabetes. J Psychosom Res 48 (2000) 37-44
9. Chantelau E., Schiffers T., Schutze J., and Hansen B. Effect of patient-selected intensive insulin therapy on quality of life. Educ Patient Couns 30 (1997) 167-173
10. Training in flexible, intensive insulin management to enable dietary freedom in people with Type 1 diabetes: dose adjustment for normal eating (DAFNE) randomized controlled trial. Diabet Med 20 Suppl. 3 (2003) 4-5
11. Howorka K. Functional insulin treatment. Principles, teaching approach and practice (1996), Springer-Verlag, Berlin
12. Muhlhauser I., Jorgens V., Berger M., Graninger W., Gurtler W., Hornke L., et al. Bicentric evaluation of a teaching and treatment programme for type 1 (insulin-dependent) diabetic patients: improvement of metabolic control and other measures of diabetes care for up to 22 months. Diabetologia 25 (1983) 470-476
13. Samann A., Muhlhauser I., Bender R., Kloos C., and Muller U.A. Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study. Diabetologia 48 (2005) 1965-1970
14. Berger W. Insulin therapy of Type I diabetes. Ther Umsch 53 (1996) 902-913
15. The DCCT Research Group. Reliability and validity of a diabetes quality-of-life measure for the diabetes control and complications trial (DCCT). Diabetes Care 11 (1988) 725-732
16. Kohlmann C.-W., Küstner E., Schuler M., and Tausch A. Der IPC-Diabetes-Fragebogen (IPC-D1): ein Inventar zur Erfassung krankheisspezifischer Kontrollüberzeugungen beim Typ-1-Diabetes mellitus; Handbuch/Carl-Walter Kohlmann (1994), Verlag Hans Huber, Bern
17. Roth R., Kulzer B., Teupe B., and Borkenstein M. Diabetes-Wissens-Test: Typ-I (DWT: Typ-I) (1996), Hogrefe Verlag für Psychologie, Göttingen
18. Ockene I.S., Matthews C.E., Rifai N., Ridker P.M., Reed G., and Stanek E. Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem 47 (2001) 444-450
19. Plank J., Kohler G., Rakovac I., Semlitsch B.M., Horvath K., Bock G., et al. Long-term evaluation of a structured outpatient education programme for intensified insulin therapy in patients with Type 1 diabetes: a 12-year follow-up. Diabetologia 47 (2004) 1370-1375
20. Hurni C.A., Perret S., Monbaron D., Gaillard R., and Ruiz J. Coronary artery disease screening in diabetic patients: how good is guideline adherence?. Swiss Med Wkly 137 (2007) 199-204
21. Hegar K.E., Schachinger H., and Berger W. Reduction of severe hypoglycemia by functional insulin therapy of type I diabetes mellitus. Schweiz Rundsch Med Prax 91 (2002) 53-60
22. Williams G.C., Freedman Z.R., and Deci E.L. Supporting autonomy to motivate patients with diabetes for glucose control. Diabetes Care 21 (1998) 1644-1651
23. Davis R.E., Morrissey M., Peters J.R., Wittrup-Jensen K., Kennedy-Martin T., and Currie C.J. Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes. Curr Med Res Opin 21 (2005) 1477-1483
24. Cox D.J., and Gonder-Frederick L. Major developments in behavioral diabetes research. J Consult Clin Psychol 60 (1992) 628-638
25. Hartemann-Heurtier A., Sachon C., Masseboeuf N., Corset E., and Grimaldi A. Functional intensified insulin therapy with short-acting insulin analog: effects on HbA1c and frequency of severe hypoglycaemia. An observational cohort study. Diabetes Metab 29 (2003) 53-57
26. Muhlhauser I., Bott U., Overmann H., Wagener W., Bender R., Jorgens V., et al. Liberalized diet in patients with type 1 diabetes. J Intern Med 237 (1995) 591-597
27. Krichbaum K., Aarestad V., and Buethe M. Exploring the connection between self-efficacy and effective diabetes self-management. Diabetes Educ 29 (2003) 653-662
28. Bott U., Jorgens V., Grusser M., Bender R., Muhlhauser I., and Berger M. Predictors of glycaemic control in type 1 diabetic patients after participation in an intensified treatment and teaching programme. Diabet Med 11 (1994) 362-371
29. Muhlhauser I., Overmann H., Bender R., Bott U., Jorgens V., Trautner C., et al. Social status and the quality of care for adult people with type I (insulin-dependent) diabetes mellitus-a population-based study. Diabetologia 41 (1998) 1139-1150